NCT01270438 Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT01263171 Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT01249352 A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT01238965 Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy Status TERMINATED Phase PHASE1
NCT01231399 Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01229111 Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers Status TERMINATED Phase PHASE2
NCT01212822 Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer Status COMPLETED Phase PHASE2
NCT01211210 Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT01206465 Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors Status COMPLETED Phase PHASE1
NCT01205711 Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01205022 Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT01198548 High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT01197664 Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery Status TERMINATED Phase PHASE1
NCT01167725 Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer Status TERMINATED Phase PHASE3
NCT01164215 Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy Status COMPLETED Phase PHASE1
NCT01154920 Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01142414 Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence Status WITHDRAWN Phase PHASE3
NCT01123473 Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer Status TERMINATED Phase PHASE2
NCT01093235 Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer Status UNKNOWN Phase PHASE3